ResearcherSir Run Run Shaw HospitalNo recent work listed
Yuelong Liang
Matched on ORCID iD 0000-0002-0693-2306; OpenAlex author ID A5077949395. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2022: 1 paper · 2023: 2 papers
Papers 3
- Identification of exosomal miR-484 role in reprogramming mitochondrial metabolism in pancreatic cancer through Wnt/MAPK axis control. Co-author DOI 10.1016/j.phrs.2023.106980↗
- Microbiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response. Last author DOI 10.3390/microorganisms11051240↗
- Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progress. Last author DOI 10.3389/fendo.2022.865655↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yiyin Zhang · 3 shared papers, 2022–2023 · strength 0.52
- Paper Microbiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response. DOI 10.3390/microorganisms11051240↗
- Paper Identification of exosomal miR-484 role in reprogramming mitochondrial metabolism in pancreatic cancer through Wnt/MAPK… DOI 10.1016/j.phrs.2023.106980↗
- Paper Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progr… DOI 10.3389/fendo.2022.865655↗
- Tianyu Lin · 2 shared papers, 2022–2023 · strength 0.33
- Paper Identification of exosomal miR-484 role in reprogramming mitochondrial metabolism in pancreatic cancer through Wnt/MAPK… DOI 10.1016/j.phrs.2023.106980↗
- Paper Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progr… DOI 10.3389/fendo.2022.865655↗
- Yi-Han Chai · 1 shared paper, 2023 · strength 0.19
- Guoping Ding · 1 shared paper, 2023 · strength 0.18
- Xiaofan Pu · 1 shared paper, 2023 · strength 0.18
- Qi Chen · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.